. 2021 Aug 17;65(9):e00698-21. doi: 10.1128/AAC.00698-21

TABLE 2.

Risk factors for mortality in patients with CRE-BSI

Variable	OR (95% CI)^a	P value
Pitt score	5.313 (3.209–8.797)	<0.001
Immunocompromised status	4.605 (1.629–13.020)	0.004
Isolate with meropenem MIC of ≥8 mg/liter	3.736 (1.091–12.795)	0.036
Source control of infection	0.316 (0.117–0.854)	0.023
Appropriate empirical therapy	0.129 (0.027–0.625)	0.011

OR, odds ratio; CI, confidence interval.